Word

CHIMIX CELL THERAPY

Status

Pending

Status Code

688

Status Date

Tuesday, February 27, 2024

Serial Number

97806112

Mark Type

4000

Filing Date

Wednesday, February 22, 2023

Published for Opposition

Tuesday, January 2, 2024

Trademark Owner History

Medeor Acquisition Corp. - Owner At Publication

Classifications

5 Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for preventing and treating rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for control and suppression of the immune system; Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for induction of immune tolerance; Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for treating and destroying cancer cells

44 Medical services, namely, processing blood and bone marrow to prevent and treat rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; Medical services, namely, processing blood and bone marrow for control and suppression of the immune system; Medical services, namely, processing blood and bone marrow for immune destruction of cancer cells; Medical services in the field of preventing and treating rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; Medical services in the field of control and suppression of the immune system; Medical services in the field of induction of immune tolerance; Medical services in the field of treating and destroying cancer cells; Medical testing for diagnostic or treatment purposes in the field of preventing and treating rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; Medical testing for diagnostic or treatment purposes in the field of control and suppression of the immune system blood analysis services

42 Clinical research in the field of human diseases; research and development services in the field of immunology and hematology; scientific, medical, and biological research; research and development in the field of pharmaceutical products

"CELL THERAPY"

Trademark Events

Feb 27, 2024

Noa E-Mailed - Sou Required From Applicant

Jan 2, 2024

Official Gazette Publication Confirmation E-Mailed

Jan 2, 2024

Published For Opposition

Dec 13, 2023

Notification Of Notice Of Publication E-Mailed

Nov 22, 2023

Approved For Pub - Principal Register

Nov 22, 2023

Examiner's Amendment Entered

Nov 22, 2023

Notification Of Examiners Amendment E-Mailed

Nov 22, 2023

Examiners Amendment E-Mailed

Nov 22, 2023

Examiners Amendment -Written

Nov 21, 2023

Assigned To Examiner

Mar 13, 2023

New Application Office Supplied Data Entered

Feb 25, 2023

New Application Entered